Protamine Sulfate is an anticoagulant reversal drug developed by the U.S. Food And Drug Administration and initially approved in 1995 for treating heparin overdosage.

Protamine Sulfate is used to prevent blood clot formation. This drug helps to counteract the anticoagulant effects of heparin. It does not thin the blood itself; instead, it neutralizes the effects of heparin, allowing the blood to clot normally.

Protamine Sulfate should be administered by slow infusion into a vein for about ten minutes by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

The side effects known to occur commonly during the treatment with Protamine Sulfate are flushing, feeling of warmth in the body, feeling sick, tiredness, and injection site reactions (redness, pain, swelling). Some serious side effects include low or high blood pressure and shortness of breath.

This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its component. Before initiating the treatment with Protamine sulfate, inform your physician if you are allergic to fish, have previously undergone heart surgery, are an insulin-dependent diabetic, or if you are a man who has had a vasectomy or is infertile. It is important to communicate this information to your physician to ensure your safety and appropriate medication use. Do not try to treat the overdose on your own. Avoid taking any additional medications or interventions without medical guidance. The management of an overdose should be under the supervision of physicians. 

Patients undergoing prolonged medical procedures involving repeated doses of this drug should be subject to careful monitoring of clotting parameters. If you suspect that you have used more Protamine sulfate than you should or if you are experiencing any signs of an overdose, it is necessary to take immediate action to ensure your safety. Inform your physician if you are pregnant, breastfeeding, suspect pregnancy, or planning to become pregnant. Please consult your doctor for more advice. This drug is not recommended for children aged twelve years and younger.

Patients receiving Protamine Sulfate should be closely monitored during and after administration to detect any signs of hypotension or adverse reactions. Vital signs, including blood pressure and heart rate, should be regularly checked.

1. Wockhardt UK Ltd, Electronic medicines compendium (EMC), [Revised on March 2018] [ Accessed on 21st Sep 2023], https://www.medicines.org.uk/emc/files/pil.8.pdf
2. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Blood coagulation and anticoagulant, fibrinolytic, and antiplatelet drugs, 12th edition, 2011, 858 - 859.
3. KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting coagulation, bleeding, and thrombosis, 7th edition, 2013, 620.

The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you are eligible to receive this treatment.